Literature DB >> 26221757

Key role of the kidney in the regulation of fibroblast growth factor 23.

Maria L Mace1,2, Eva Gravesen2, Jacob Hofman-Bang2, Klaus Olgaard2, Ewa Lewin1,2.   

Abstract

High circulating levels of fibroblast growth factor 23 (FGF23) have been demonstrated in kidney failure, but mechanisms of this are not well understood. Here we examined the impact of the kidney on the early regulation of intact FGF23 in acute uremia as induced by bilateral or unilateral nephrectomy (BNX and UNX, respectively) in the rat. BNX induced a significant increase in plasma intact FGF23 levels from 112 to 267 pg/ml within 15 min, which remained stable thereafter. UNX generated intact FGF23 levels between that seen in BNX and sham-operated rats. The intact to C-terminal FGF23 ratio was significantly increased in BNX rats. The rapid rise in FGF23 after BNX was independent of parathyroid hormone or FGF receptor signaling. No evidence of early stimulation of FGF23 gene expression in the bone was found. Furthermore, acute severe hyperphosphatemia or hypercalcemia had no impact on intact FGF23 levels in normal and BNX rats. The half-life of exogenous recombinant human FGF23 was significantly prolonged from 4.4 to 11.8 min in BNX rats. Measurements of plasma FGF23 in the renal artery and renal vein demonstrated a significant renal extraction. Thus the kidney is important in FGF23 homeostasis by regulation of its plasma level and metabolism.

Entities:  

Year:  2015        PMID: 26221757     DOI: 10.1038/ki.2015.231

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  87 in total

1.  Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men.

Authors:  Serge L Ferrari; Jean-Philippe Bonjour; René Rizzoli
Journal:  J Clin Endocrinol Metab       Date:  2004-12-21       Impact factor: 5.958

Review 2.  Fibroblast growth factor 23 and Klotho: physiology and pathophysiology of an endocrine network of mineral metabolism.

Authors:  Ming Chang Hu; Kazuhiro Shiizaki; Makoto Kuro-o; Orson W Moe
Journal:  Annu Rev Physiol       Date:  2013       Impact factor: 19.318

3.  Circulating FGF-23 is regulated by 1alpha,25-dihydroxyvitamin D3 and phosphorus in vivo.

Authors:  Hitoshi Saito; Akira Maeda; Shu-Ichi Ohtomo; Michinori Hirata; Kenichiro Kusano; Shigeaki Kato; Etsuro Ogata; Hiroko Segawa; Ken-Ichi Miyamoto; Naoshi Fukushima
Journal:  J Biol Chem       Date:  2004-11-05       Impact factor: 5.157

4.  Circulating FGF23 levels in response to acute changes in plasma Ca(2+).

Authors:  Eva Gravesen; Maria L Mace; Jacob Hofman-Bang; Klaus Olgaard; Ewa Lewin
Journal:  Calcif Tissue Int       Date:  2014-05-07       Impact factor: 4.333

5.  Circulating fibroblast growth factor 23 in patients with end-stage renal disease treated by peritoneal dialysis is intact and biologically active.

Authors:  Takashi Shimada; Itaru Urakawa; Tamara Isakova; Yuji Yamazaki; Michael Epstein; Katherine Wesseling-Perry; Myles Wolf; Isidro B Salusky; Harald Jüppner
Journal:  J Clin Endocrinol Metab       Date:  2009-12-04       Impact factor: 5.958

6.  Venous sampling for fibroblast growth factor-23 confirms preoperative diagnosis of tumor-induced osteomalacia.

Authors:  Yasuhiro Takeuchi; Hisanori Suzuki; Sayoko Ogura; Rie Imai; Yuji Yamazaki; Takeyoshi Yamashita; Yoshinari Miyamoto; Hiroshi Okazaki; Kozo Nakamura; Kazuhiko Nakahara; Seiji Fukumoto; Toshiro Fujita
Journal:  J Clin Endocrinol Metab       Date:  2004-08       Impact factor: 5.958

7.  Parathyroid hormone regulates fibroblast growth factor-23 in a mouse model of primary hyperparathyroidism.

Authors:  Takehisa Kawata; Yasuo Imanishi; Keisuke Kobayashi; Takami Miki; Andrew Arnold; Masaaki Inaba; Yoshiki Nishizawa
Journal:  J Am Soc Nephrol       Date:  2007-09-12       Impact factor: 10.121

8.  Involvement of alpha-klotho and fibroblast growth factor receptor in the development of secondary hyperparathyroidism.

Authors:  Chiaki Kumata; Masahide Mizobuchi; Hiroaki Ogata; Fumihiko Koiwa; Ai Nakazawa; Fumiko Kondo; Yoshiyuki Kadokura; Eriko Kinugasa; Tadao Akizawa
Journal:  Am J Nephrol       Date:  2010-01-06       Impact factor: 3.754

Review 9.  Insights from genetic disorders of phosphate homeostasis.

Authors:  Marta Christov; Harald Jüppner
Journal:  Semin Nephrol       Date:  2013-03       Impact factor: 5.299

10.  Calcium deficiency reduces circulating levels of FGF23.

Authors:  María E Rodriguez-Ortiz; Ignacio Lopez; Juan R Muñoz-Castañeda; Julio M Martinez-Moreno; Alan Peralta Ramírez; Carmen Pineda; Antonio Canalejo; Philippe Jaeger; Escolastico Aguilera-Tejero; Mariano Rodriguez; Arnold Felsenfeld; Yolanda Almaden
Journal:  J Am Soc Nephrol       Date:  2012-05-10       Impact factor: 10.121

View more
  29 in total

Review 1.  Fibroblast growth factor 21 in chronic kidney disease.

Authors:  Paulo Giovanni de Albuquerque Suassuna; Rogério Baumgratz de Paula; Hélady Sanders-Pinheiro; Orson W Moe; Ming-Chang Hu
Journal:  J Nephrol       Date:  2018-11-14       Impact factor: 3.902

2.  Fibroblast growth factor 23 levels are elevated and associated with severe acute kidney injury and death following cardiac surgery.

Authors:  David E Leaf; Marta Christov; Harald Jüppner; Edward Siew; T Alp Ikizler; Aihua Bian; Guanhua Chen; Venkata S Sabbisetti; Joseph V Bonventre; Xuan Cai; Myles Wolf; Sushrut S Waikar
Journal:  Kidney Int       Date:  2016-02-17       Impact factor: 10.612

Review 3.  Extrarenal effects of FGF23.

Authors:  Dieter Haffner; Maren Leifheit-Nestler
Journal:  Pediatr Nephrol       Date:  2016-10-04       Impact factor: 3.714

4.  Fibroblast Growth Factor 23 Levels Associate with AKI and Death in Critical Illness.

Authors:  David E Leaf; Kirolos A Jacob; Anand Srivastava; Margaret E Chen; Marta Christov; Harald Jüppner; Venkata S Sabbisetti; Aline Martin; Myles Wolf; Sushrut S Waikar
Journal:  J Am Soc Nephrol       Date:  2016-12-27       Impact factor: 10.121

Review 5.  Effects of klotho deletion from bone during chronic kidney disease.

Authors:  Jovana Kaludjerovic; Hirotaka Komaba; Beate Lanske
Journal:  Bone       Date:  2017-02-20       Impact factor: 4.398

Review 6.  New concepts in regulation and function of the FGF23.

Authors:  Sanaz Dastghaib; Farhad Koohpeyma; Mesbah Shams; Forough Saki; Aliakbar Alizadeh
Journal:  Clin Exp Med       Date:  2022-06-16       Impact factor: 3.984

7.  Effect of chronic uremia on the transcriptional profile of the calcified aorta analyzed by RNA sequencing.

Authors:  Jakob L Rukov; Eva Gravesen; Maria L Mace; Jacob Hofman-Bang; Jeppe Vinther; Claus B Andersen; Ewa Lewin; Klaus Olgaard
Journal:  Am J Physiol Renal Physiol       Date:  2016-01-06

Review 8.  Fibroblast Growth Factor 23 and αKlotho in Acute Kidney Injury: Current Status in Diagnostic and Therapeutic Applications.

Authors:  Javier A Neyra; Ming Chang Hu; Orson W Moe
Journal:  Nephron       Date:  2020-08-25       Impact factor: 2.847

9.  Aldosterone Is Positively Associated With Circulating FGF23 Levels in Chronic Kidney Disease Across Four Species, and May Drive FGF23 Secretion Directly.

Authors:  Judith Radloff; Maximilian Pagitz; Olena Andrukhova; Rainer Oberbauer; Iwan A Burgener; Reinhold G Erben
Journal:  Front Physiol       Date:  2021-04-29       Impact factor: 4.566

Review 10.  Serum fibroblast growth factor 23 for early detection of acute kidney injury in critical illness.

Authors:  Shu Sun; Zhijia Liu; Changqing Chen; Zhisong Wang; Hailong Jin; Xiaoyun Meng; Bing Dai; Liming Zhang; Chenchen Zhou; Cheng Xue; Xiang Li
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.